One challenge is limited commercial synergy. Rare disease markets are often fragmented, with small prescriber bases and ...
At the India AI Impact Summit, Beyond Key’s Ananya Sharma and Vishal Gupte told Firstpost that India’s AI future hinges on stronger data infrastructure, localised large language models, affordable ...